The Global Health Body Issues Alert Over Acute Scarcity of Obesity Injections
Fewer than one in 10 individuals eligible to benefit from weight-loss injections like Wegovy can access them, caution the global health agency as it releases its inaugural recommendations on the therapies.
With in excess of 1,000,000,000 individuals worldwide currently living with obesity, it is urging increased and just access to this class of drugs.
According to estimates, in excess of 2,000,000,000 are projected to be living with obesity by 2030 unless action is taken.
"Our new guidelines acknowledges that obesity is a long-term condition that can be managed with holistic and lifelong treatment," stated WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, limited production capacity, and logistical bottlenecks are key barriers to broad availability to the injections that can help people shift considerable body mass, explains the body.
GLP-1 Therapy Shortage
Even in the current most optimistic outlook, the manufacturing of GLP-1 therapies would only suffice for approximately 100 million people – less than 10% of eligible patients, according to the health organization.
The recommendation calls on governments and firms to expand access, via strategies such as voluntary licensing.
Exclusive production rights on a key compound – the core component of a leading brand – is scheduled to end in several countries in 2026.
The Way Obesity Drugs Operate
The injections replicate a natural hormone to slow digestion, suppress the appetite and boost the sense of being full so people eat less.
People commonly begin shedding pounds in the initial weeks of beginning the regular doses.
Studies indicates users may see weight return a year later of discontinuing the drug, as their normal food cravings return.
To be overweight or obese elevates your likelihood for experiencing health problems, including diabetes, cardiovascular issues, brain attack, and certain malignancies.
Excess weight impacts people in every country and was associated with millions of deaths worldwide in 2024, according to the WHO.
